Atlas Venture Life Science Advisors »

Kailera Therapeutics shares owned by Atlas Venture Life Science Advisors

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Atlas Venture Life Science Advisors from 13F filings

Historical chart of Atlas Venture Life Science Advisors investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Atlas Venture Life Science Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Atlas Venture Life Science Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $114M 5.2M 22.03

More positions owned by Atlas Venture Life Science Advisors

Kymera Therapeutics Common Stock (KYMR)
Dyne Therapeutics Common Stock (DYN)
Sionna Therapeutics Common Stock (SION)
Kailera Therapeutics Common Stock
Disc Medicine Common Stock (IRON)
Q32 Bio Common Stock (QTTB)
Korro Bio Common Stock (KRRO)

View all positions for Atlas Venture Life Science Advisors

Top funds holding Kailera Therapeutics

Bain Capital Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management
Farallon Capital Management
Trails Edge Capital Partners
UBS Group
Jupiter Topco

View all funds holding Kailera Therapeutics